These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35380160)

  • 41. Activin A is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes.
    Chen WJ; Greulich S; van der Meer RW; Rijzewijk LJ; Lamb HJ; de Roos A; Smit JW; Romijn JA; Ruige JB; Lammertsma AA; Lubberink M; Diamant M; Ouwens DM
    Cardiovasc Diabetol; 2013 Oct; 12():150. PubMed ID: 24134550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload.
    von Lueder TG; Gravning J; How OJ; Vinge LE; Ahmed MS; Krobert KA; Levy FO; Larsen TS; Smiseth OA; Aasum E; Attramadal H
    Am J Physiol Heart Circ Physiol; 2012 Jul; 303(1):H66-74. PubMed ID: 22542621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activin inhibition limits early innate immune response in rat kidney allografts-a pilot study.
    Palin NK; Savikko J; Pasternack A; Rintala JM; Kalra B; Mistry S; Kumar A; Roth MP; Helin H; Ritvos O
    Transpl Int; 2017 Jan; 30(1):96-107. PubMed ID: 27732750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oleic Acid Attenuates Ang II (Angiotensin II)-Induced Cardiac Remodeling by Inhibiting FGF23 (Fibroblast Growth Factor 23) Expression in Mice.
    Liu T; Wen H; Li H; Xu H; Xiao N; Liu R; Chen L; Sun Y; Song L; Bai C; Ge J; Zhang Y; Chen J
    Hypertension; 2020 Mar; 75(3):680-692. PubMed ID: 31928110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium.
    Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R
    Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitochondrial impairment induced by postnatal ActRIIB blockade does not alter function and energy status in exercising mouse glycolytic muscle in vivo.
    Béchir N; Pecchi É; Relizani K; Vilmen C; Le Fur Y; Bernard M; Amthor H; Bendahan D; Giannesini B
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E539-49. PubMed ID: 26837807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Partial inhibition of activin receptor-like kinase 4 attenuates pressure overload-induced cardiac fibrosis and improves cardiac function.
    Li CY; Chen YH; Wang Q; Hou JW; Wang H; Wang YP; Li YG
    J Hypertens; 2016 Sep; 34(9):1766-77. PubMed ID: 27379535
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway.
    Zheng J; Tian J; Wang S; Hu P; Wu Q; Shan X; Zhao P; Zhang C; Guo W; Xu M; Chen H; Lu R
    Eur J Pharmacol; 2020 Sep; 883():173386. PubMed ID: 32712088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of Activin/Myostatin signalling induces skeletal muscle hypertrophy but impairs mouse testicular development.
    Vaughan D; Ritvos O; Mitchell R; Kretz O; Lalowski M; Amthor H; Chambers D; Matsakas A; Pasternack A; Collins-Hooper H; Ballesteros R; Huber TB; Denecke B; Widera D; Mukherjee A; Patel K
    Eur J Transl Myol; 2020 Apr; 30(1):8737. PubMed ID: 32499882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. OBG-like ATPase 1 inhibition attenuates angiotensin II-induced hypertrophic response in human ventricular myocytes via GSK-3beta/beta-catenin signalling.
    Narasimhan G; Henderson J; Luong HT; Rajasekaran NS; Qin G; Zhang J; Krishnamurthy P
    Clin Exp Pharmacol Physiol; 2019 Aug; 46(8):743-751. PubMed ID: 31063653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of IgE-FcεR1 in Pathological Cardiac Remodeling and Dysfunction.
    Zhao H; Yang H; Geng C; Chen Y; Pang J; Shu T; Zhao M; Tang Y; Li Z; Li B; Hou C; Song X; Wu A; Guo X; Chen S; Liu B; Yan C; Wang J
    Circulation; 2021 Mar; 143(10):1014-1030. PubMed ID: 33305586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing the role of extracellular signal-regulated kinases 1 and 2 in volume overload-induced cardiac remodelling.
    Jochmann S; Elkenani M; Mohamed BA; Buchholz E; Lbik D; Binder L; Lorenz K; Shah AM; Hasenfuß G; Toischer K; Schnelle M
    ESC Heart Fail; 2019 Oct; 6(5):1015-1026. PubMed ID: 31322843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allopurinol attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction.
    Jia N; Dong P; Ye Y; Qian C; Dai Q
    Cardiovasc Ther; 2012 Apr; 30(2):117-23. PubMed ID: 20973927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TGFB-INHB/activin signaling regulates age-dependent autophagy and cardiac health through inhibition of MTORC2.
    Chang K; Kang P; Liu Y; Huang K; Miao T; Sagona AP; Nezis IP; Bodmer R; Ocorr K; Bai H
    Autophagy; 2020 Oct; 16(10):1807-1822. PubMed ID: 31884871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD1d-dependent natural killer T cells attenuate angiotensin II-induced cardiac remodelling via IL-10 signalling in mice.
    Wang HX; Li WJ; Hou CL; Lai S; Zhang YL; Tian C; Yang H; Du J; Li HH
    Cardiovasc Res; 2019 Jan; 115(1):83-93. PubMed ID: 29939225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of transient receptor potential vanilloid 4 is involved in pressure overload-induced cardiac hypertrophy.
    Zou Y; Zhang M; Wu Q; Zhao N; Chen M; Yang C; Du Y; Han B
    Elife; 2022 Jun; 11():. PubMed ID: 35731090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling.
    Li G; Shao Y; Guo HC; Zhi Y; Qiao B; Ma K; Du J; Lai YQ; Li Y
    Cardiovasc Res; 2022 Jul; 118(9):2139-2151. PubMed ID: 34358309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.
    Liu J; Liu X; Hui X; Cai L; Li X; Yang Y; Shu S; Wang F; Xia H; Li S
    J Am Heart Assoc; 2019 Aug; 8(16):e011830. PubMed ID: 31426686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
    Li L; Li J; Drum BM; Chen Y; Yin H; Guo X; Luckey SW; Gilbert ML; McKnight GS; Scott JD; Santana LF; Liu Q
    Cardiovasc Res; 2017 Feb; 113(2):147-159. PubMed ID: 27856611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.